• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

T1 high-grade bladder cancer recurring after BCG therapy: a curative alternative to radical cystectomy exists. Con.

作者信息

Gray Phillip J, Shipley William U, Efstathiou Jason A

机构信息

Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Oncology (Williston Park). 2013 Sep;27(9):873, 921.

PMID:24282983
Abstract
摘要

相似文献

1
T1 high-grade bladder cancer recurring after BCG therapy: a curative alternative to radical cystectomy exists. Con.
Oncology (Williston Park). 2013 Sep;27(9):873, 921.
2
T1 high-grade bladder cancer recurring after BCG therapy: radical cystectomy is still the best approach. Pro.卡介苗治疗后复发的T1期高级别膀胱癌：根治性膀胱切除术仍是最佳治疗方法。专家观点。
Oncology (Williston Park). 2013 Sep;27(9):872, 921.
3
Management of high-risk non-muscle invasive bladder cancer.高危非肌层浸润性膀胱癌的管理
Minerva Urol Nefrol. 2012 Dec;64(4):255-60.
4
The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?卡介苗治疗非肌层浸润性膀胱癌后复发的同步放化疗结果：是否总是需要立即进行膀胱切除术？
BJU Int. 2009 Jul;104(2):179-83. doi: 10.1111/j.1464-410X.2008.08299.x. Epub 2008 Dec 23.
5
Cystectomy in patients with high risk superficial bladder tumors who fail intravesical BCG therapy: pre-cystectomy prostate involvement as a prognostic factor.高危浅表性膀胱肿瘤患者膀胱内卡介苗治疗失败后的膀胱切除术：术前前列腺受累作为一个预后因素。
Eur Urol. 2005 Jul;48(1):53-9; discussion 59. doi: 10.1016/j.eururo.2005.03.021. Epub 2005 Apr 7.
6
Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.膀胱内卡介苗治疗T1期3级膀胱移行细胞癌：57例患者的复发、进展及生存情况研究
J Urol. 2003 Jun;169(6):2110-2. doi: 10.1097/01.ju.0000066840.42991.4a.
7
An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer.对新诊断的高级别 T1（以前为 T1G3）膀胱癌的治疗策略进行的最新批判性分析。
Eur Urol. 2010 Jan;57(1):60-70. doi: 10.1016/j.eururo.2009.08.024. Epub 2009 Sep 1.
8
[Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].[卡介苗辅助膀胱内灌注治疗3级浅表性膀胱癌的结果]
Hinyokika Kiyo. 2004 Nov;50(11):767-71.
9
Management of the first recurrence of T1G3 bladder cancer: does intravesical chemotherapy deserve a chance?
Urol Oncol. 2009 May-Jun;27(3):322-4. doi: 10.1016/j.urolonc.2008.10.027.
10
[BCG Immunotherapy Against Non-Muscle Invasive Bladder Cancer: Recent Results, Current Studies and Future Perspectives].
Fukuoka Igaku Zasshi. 2016 Jan;107(1):8-11.

引用本文的文献

1
Immunotherapy and Radiation - A New Combined Treatment Approach for Bladder Cancer?免疫疗法与放疗——膀胱癌的一种新的联合治疗方法？
Bladder Cancer. 2015 Apr 30;1(1):15-27. doi: 10.3233/BLC-150014.